Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology

Hypertension

Volumn 29, Issue 3, 1997, Pages 691-699

  Sowers, James R ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; INSULIN; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN; POTASSIUM CHLORIDE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADRENERGIC SYSTEM; ANIMAL TISSUE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; CARBOHYDRATE METABOLISM; CARDIOVASCULAR EFFECT; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; HORMONE ACTION; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0031019043     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.29.3.691     Document Type: Conference Paper

References (157)

1. Sowers JR, Epstein M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy: an update. Hypertension. 1995;26:869-879.
2. Yagi S, Takata S, Kiyokawa H, Yamamoto M, Noto Y, Ikeda M, Hattori N. Effects of insulin on vasoconstrictive responses to norepinephrine and angiotensin II in rabbit femoral artery and vein. Diabetes. 1988;37:1064-1067.
3. Reddy S, Shehin S, Sowers JR. Aortic calcium-45 flux and blood pressure regulation in streptozotocin-induced diabetic rats. J Vasc Med Biol. 1990;2:47-51.
4. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 1991;87:2246-2252.
5. Standley PR, Zhang F, Ram JL, Zemel MB, Sowers JR. Insulin attenuates vasopressin-induced calcium transient and voltage-dependent calcium response in rat vascular smooth muscle cells. J Clin Invest. 1991;88:1230-1236.
6. Saito F, Hori MT, Fittingott M, Hino R, Tuck ML. Insulin attenuates agonist-mediated calcium mobilization in cultured rat vascular smooth muscle cells. J Clin Invest. 1993;92:1161-1168.
7. Kahn AM, Seidel CL, Allen JC, O'Neil RG, Shelat H, Song T. Insulin reduces contraction and intracellular calcium concentration in vascular smooth muscle. Hypertension. 1993;22:735-742.
8. Bornfeldt KE, Arnqvist HJ, Norstedt G. Regulation of insulin-like growth factor-1 gene expression by growth factors in cultured vascular smooth muscle cells. J Endocrinol. 1990;125:381-386.
9. Khorsandi MJ, Fagin JA, Giannella-Neto D, Forrester JS, Cercek B. Regulation of insulin-like growth factor-1 and its receptor in rat aorta after balloon denudation: evidence for local bioactivity. J Clin Invest. 1992;90:1926-1931.
10. Delafontaine P, Lou H. Angiotensin II regulates insulin-like growth factor 1 gene expression in vascular smooth muscle cells. J Biol Chem. 1993;268:16866-16870.
11. Fath KA, Alexander RW, Delafontaine P. Abdominal coarctation increases insulin-like growth factor I mRNA levels in rat aorta. Circ Res. 1993;72:271-277.
12. Giannella-Neto D, Kamyar A, Sharifi B, Pirola CJ, Kupfer J, Rosenfeld RG, Forrester JS, Fagin JA. Platelet-growth factor isoforms decrease insulin-like growth factor I gene expression in rat vascular smooth muscle cells and selectively stimulate the biosynthesis of insulin-like growth factor binding protein 4. Circ Res. 1992;71:646-656.
13. Tsukahara H, Gordienko DV, Toushoff B, Gelato MC, Goligorsky MS. Direct demonstration of insulin-like growth factor-1-induced nitric oxide production by endothelial cells. Kidney Int. 1994;45: 598-604.
14. Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by Wortmannin direct measurement in vascular endothelial cells that are also involved with glucose metabolism. J Clin Invest. 1996;98:894-898.
15. Ram JL, Fares MA, Standley PR, Therill LL, Thyagarajan RV, Sowers JR. Insulin inhibits vasopressin-elicited contraction of vascular smooth muscle cells. J Vasc Med Biol. 1993;4:250-254.
16. Standley PR, Ram JL, Sowers JR. Insulin attenuation of vasopressin-induced calcium responses in arterial smooth muscle from Zucker rats. Endocrinology. 1993;133:1693-1699.
17. Scherrer U, Vollenweider P, Randin D, Jéquier E, Nicod P, Tappy L. Suppression of insulin-induced sympathetic activation and vasodilation by dexamethasone in humans. Circulation. 1993;88:388-394.
18. Baron AD, Brechtel G. Insulin differentially regulates systemic and skeletal muscle vascular resistance. Am J Physiol. 1993;265:E61-E67.
19. Sakai K, Imaizumi T, Masaki H, Takeshita A. Intra-arterial infusion of insulin attenuates vasoreactivity in human forearm. Hypertension. 1993;22:67-73.
20. Zaninetti D, Greco-Perotto R, Assimacopoulos-Jeannet F, Jeanrenaud B. Effects of insulin on glucose transport and glucose transporters in rat heart. Biochem J 1988;250:277-283.
21. Eckel J, Gerlach-Eskuchen E, Reinauer H. G-protein-mediated regulation of the insulin-responsive glucose transporter in isolated cardiac myocytes. Biochem J. 1990;272:691-696.
22. Kraegen EW, Sowden JA, Halstead MB, Clark PW, Rodnick KJ, Chisholm DJ, James DE. Glucose transporters and in vivo glucose uptake in skeletal and cardiac muscle: fasting, insulin stimulation and immunoisolation studies of GLUT1 and GLUT4. Biochem J. 1993;295:287-293.
23. Sun D, Nguyen N, DeGrado FR, Schwarger M, Brosius FC III. Ischemia induces translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes. Circulation. 1994;89:793-798.
24. Berweck S, Hagen T, Lepple-Wienhues A, Helbig H, Wiederhold M. Insulin-induced hyperpolarization in retinal capillary pericytes. Invest Ophthalmol Vis Sci. 1993;34:3402-3407.
25. Touyz RM, Tolloczko B, Schiffrin EL. Insulin attenuates agonist-evoked calcium transients in vascular smooth muscle cells. Hypertension. 1994;23(suppl I):I-25-I-28.
26. 2+ influx in vascular smooth muscle. Circulation. 1994;90:384-390.
27. 2+ level and contraction in the rat aorta: endothelium-dependent and -independent mechanisms. Circ Res. 1995;77:673-678.
28. 2-adrenergic pathway in humans. Hypertension. 1994;24:429-438.
29. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest. 1994;94:1172-1179.
30. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts form insulin's vascular effects in humans. J Clin Invest. 1994;94:2511-2515.
31. Wu H, Jeng YY, Yue C, Chyu KY, Hsueh W, Chan T. Endothelial-dependent vascular effects of insulin and insulin-like growth factor 1 in the perfused rat mesenteric artery and aortic ring. Diabetes. 1994;43:1027-1032.
32. Lembo G, Iaccarino G, Vecchione C, Rendina V, Trimarco B. Insulin modulation of vascular reactivity is already impaired in prehypertensive SHR. Hypertension. 1995;26:290-293.
33. Gross R, Borkowski KR, Feldman RD. Human insulin-mediated enhancement of vascular β-adrenergic responsiveness. Hypertension. 1994;23:551-555.
34. Baron AD, Steinberg H, Brechtel G, Johnson A. Skeletal muscle blood flow independently modulates insulin-mediated glucose uptake. Am J Physiol. 1994;266:E248-E253.
35. Grover A, Padginton C, Wilson MF, Sung BH, Izzo JL Jr, Dandona P. Insulin attenuates norepinephrine-induced venoconstriction: an ultrasonographic study. Hypertension. 1995;25:779-784.
36. Copeland KC, Streekuran K. Recombinant human insulin-like growth factor-1 increases forearm blood flow. J Clin Endocrinol Metab. 1994;79:230-232.
37. Kahn AM, Song T. Effects of insulin on vascular smooth muscle contraction. In: Sowers JR, ed. Endocrinology of the Vasculature. Totowa, NJ: Humana Press; 1996:215-223.
38. Sowers JR. Effects of insulin and IGF-1 on vascular smooth muscle glucose and cation metabolism. Diabetes. 1996;45:47-51.
39. Walsh MF, Barazi M, Pete G, Muniyappa R, Dunbar JC, Sowers JR. Insulin-like growth factor 1 diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide. Endocrinology. 1996;137:1798-1803.
40. Baron AD, Steinberg HO. Vascular actions of insulin in health and disease. In: Sowers JR, ed. Endocrinology of the Vasculature. Totowa, NJ: Humana Press; 1996:95-107.
41. Bakris GL, Palant CE, Walsh MF, Sowers JR. Analogy between endothelial/mesangial cell and endothelial/vascular smooth muscle cell interactions: role of growth factors and mechanotransduction. In: Sowers JR, ed. Endocrinology of the Vasculature. Totowa, NJ: Humana Press; 1996:341-355.
42. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathetic adrenal system. N Engl J Med. 1996;334:374-381.
43. Pyorala K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two populations studies in Finland. Diabetes Care. 1979;2:131-141.
44. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care. 1979;2:154-160.
45. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin level to the incidence of myocardial infarction and coronary heart disease. Diabetologia. 1980;19:205-210.
46. Foumier AM, Gadia MT, Kubrusly DB, Skyler JS, Sosenko JM. Blood pressure, insulin, and glycemia in nondiabetic subjects. Am J Med. 1986;80:861-884.
47. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Giuseppe B, Bonati PA, Bergonzani M, Gnudi L, Passeri M, Reaven G. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med. 1989;320:702-706.
48. Manicardi V, Camellini L, Bellodi G, Coscelli C, Ferrannini E. Evidence for an association of high blood pressure and hyperinsulinemia in obese men. J Clin Endocrinol Metab. 1986;62:1302-1304.
49. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z. Hyperinsulinemia: a link between obesity and glucose intolerance. J Clin Invest. 1985;75:809-817.
50. Modan M, Halkin H, Lusky A, Segal P, Fuchs Z, Chetrit A. Hyperinsulinemia is characterized by jointly disturbed plasma VLDL, LDL, and HDL levels. Arteriosclerosis. 1988;8:227-236.
51. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Gradiadei L, Pendrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350-357.
52. Manolio TA, Savage PJ, Burke GL, Liu KL, Wagenknecht LE, Sidney S, Jacobs DR, Roseman JM, Donahue RP, Oberman A. Association of fasting insulin with blood pressure and lipids in young adults: the CARDIA study. Arteriosclerosis. 1990;10:430-436.
53. Landin K, Lonnroth M, Krotkiewski M, Holm G, Smith U. Increased insulin resistance and fat cell lipolysis in obese but not lean women with a high waist/hip ratio. Eur J Clin Invest. 1990;20: 530-535.
54. Stolar MW. Atherosclerosis in diabetics: the role of hyperinsulinemia. Metabolism. 1988;37:1-9.
55. Hall JE, Coleman TG, Mizelle HL, Smith MJ. Chronic hyperinsulinemia and blood pressure regulation. Am J Physiol. 1990;258: F722-F731.
56. Haffner SM, Stern MP, Hazuda HP. Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA. 1990;263:2893-2898.
57. Flack JM, Sowers JR. Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia. Am J Med. 1991;Suppl 1A:11S-20S.
58. Laakso M, Edelman SV, Brechtel G, Baron D. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese men: a novel mechanism for insulin resistance. J Clin Invest. 1990;85:1844-1852.
59. Tappy L, Bovet P, Jequier E, Shamlaye C, Darioli R, Burnand B. Relationship of fasting serum insulin concentrations with blood pressure in a representative sample of the adult population of the Seychelles. Int J Obes Relat Metab Disord. 1991;15:669-675.
60. Laakso M, Sarlund H, Salonen R, Suhonen M, Pyörälä K, Salonen JT, Karhapää P. Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb. 1991;11:1068-1076.
61. Supiano MA, Hogikyan RV, Morrow LA. Hypertension and insulin resistance: role of sympathetic nerve system activity. Am J Physiol. 1992;263:E935-E942.
62. Laakso M, Edelman SV, Brechtel G, Baron AD. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes. 1992;41:1076-1083.
63. Hall JE, Brands MW, Dixon WN, Smith MJ Jr. Obesity-induced hypertension: renal function and systemic hemodynamics. Hypertension. 1993;22:292-299.
64. Johnstone MT, Craeger SJ, Scales KM, Cusco JA, Lee BK, Craeger MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 1993;88:2510-2516.
65. Lembo G, Rendina V, Iaccarino G, Lamenza F, Volpe M, Trimarco B. Insulin does not modulate reflex forearm sympathetic vasoconstriction in patients with essential hypertension. J Hypertens. 1993;11:S272-S273.
66. Feldman RD, Bierbrier GS. Insulin mediated vasodilation: impairment with increased blood pressure and body mass. Lancet. 1993;342:707-709.
67. Baron AD, Brechtel-Hook G, Johnson A, Hardin D. Skeletal muscle blood flow: a possible link between insulin resistance and blood pressure. Hypertension. 1993;21:129-135.
68. Sowers JR, Standley PR, Ram JL, Jacober SJ, Simpson LL, Rose K. Hyperinsulinemia, insulin resistance, and hyperglycemia: contributing factors in the pathogenesis of hypertension and atherosclerosis. Am J Hypertens. 1993;6:260S-270S.
69. Sowers JR, Sowers PS, Peuler JD. Role of insulin resistance and hyperinsulinemia in development of hypertension and atherosclerosis. J Lab Clin Med. 1994;123:647-652.
70. Eschwège E, Richard JL, Thibult N. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels: the Paris Prospective Study, ten years later. Horm Metab Res. 1985;15:41-46.
71. Pouliot MC, Després JP, Nadeau A. Visceral obesity in men: associations with glucose tolerance, plasma insulin and lipoprotein levels. Diabetes. 1992;41:826-834.
72. Casassus P, Fontbonne A, Thibult N. Upper-body fat distribution: a hyperinsulinemia-independent predictor of coronary heart disease mortality: the Paris Prospective Study. Arterioscler Thromb. 1992;12:1387-1392.
73. Haffner SM, Mykkänen L, Stern MP, Valdez RA, Heisserman JA, Bowsher RR. Relationship of proinsulin and insulin to cardiovascular risk factors in nondiabetic subjects. Diabetes. 1993;42: 1297-1302.
74. Haffner SM, Karhapää P, Mykkänen L, Laakso M. Insulin resistance, body fat distribution and sex hormones in men. Diabetes. 1994;43:212-219.
75. Ferrara LA, Mancini M, Celentano A, Galderisi M, Iannuzzi R, Marotta T, Gaeta I. Early changes of the arterial carotid wall in uncomplicated primary hypertensive patients. Arterioscler Thromb. 1994;14:1290-1296.
76. Folsom AR, Eckfeldt JH, Weitzman S, Ma J, Chambless LE, Barnes RW, Cram KB, Hutchinson RG. Atherosclerosis Risk in Communities (ARIC) Study Investigators: relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Stroke. 1994;25:66-73.
77. Salomaa V, Riley W, Kark JD, Nardo C, Folsom AR. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes: the ARIC study. Circulation. 1995;91:1432-1443.
78. Agewall S, Fagerberg B, Attvall S, Wendelhag I, Urbanavicius V, Wikstrand J. Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk. Stroke. 1995;26:956-960.
79. Shinozaki K, Suzuki M, Ikebuchi M, Takaki H, Hara Y, Tsushima M, Harano Y. Insulin resistance associated with compensatory hyperinsulinemia as an independent risk factor for vasospastic angina. Circulation. 1995;92:1749-1757.
80. Shinozaki K, Naritomi H, Shimizu T, Suzuki M, Ikebuchi M, Sawada T, Harano Y. Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke. Stroke. 1996; 27:37-43.
81. Suzuki M, Shinozaki K, Kanazawa A, Hara Y, Hattori Y, Tsushima M, Harano Y. Insulin resistance as an independent risk for carotid wall thickening. Hypertension. 1996;28:593-598.
82. Walsh MF, Dominguez LJ, Sowers JR. Metabolic abnormalities in cardiac ischemia. Cardiol Clin. 1995;13:529-538.
83. Després J-P, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien P-J. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334:952-957.
84. Jamerson KA, Julius S, Gudbrandsson T, Andersson O, Brant DO. Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension. 1992;21:618-623.
85. Ganrot PO. Insulin resistance syndrome: possible key role of blood flow in resting muscle. Diabetologia. 1993;36:876-879.
86. Rao HR. Insulin resistance in spontaneously hypertensive rats: difference in interpretation based on insulin and glucose clamp studies. Diabetes. 1993;42:1364-1371.
87. Rocchini AP, Moorehead C, DeRemer S, Goodfriend TL, Ball DL. Hyperinsulinemia and the aldosterone and pressor responses to angiotensin II. Hypertension. 1990;15:861-866.
88. Brands MW, Hildebrandt DA, Mizelle HL, Hall JE. Sustained hyperinsulinemia increases arterial pressure in conscious rats. Am J Physiol. 1991;260:R764-R768.
89. Brands MW, Hildebrandt DA, Mizelle HL, Hall JE. Hypertension during chronic hyperinsulinemia in rats is not salt-sensitive. Hypertension. 1992;19(suppl I):I-83-I-89.
90. Zemel MB, Peuler JD, Sowers JR. Hypertension in insulin-resistant Zucker obese rats is independent of sympathetic neural support. Am J Physiol. 1992;262:E368-E371.
91. Natali A, Bonadonna R, Santoro D, Quiñones Galvan A, Baldi S, Frascerra S, Palombo C, Ghione S, Ferrannini E. Insulin resistance and vasodilation in essential hypertension: studies with adenosine. J Clin Invest. 1994;94:1570-1576.
92. Lembo G, Capaldo B, Rendina V, Iaccarino G, Napoli R, Guida R, Trimarco B, Saccá L. Acute nonadrenergic activation induces insulin resistance in human skeletal muscle. Am J Physiol. 1993;266: E242-E247.
93. Gaboury CL, Simonson DC, Seely EW, Hollenberg NK, Williams GH. Relation of pressor responsiveness to angiotensin II and insulin resistance in hypertension. J Clin Invest. 1994;94:2295-2300.
94. Hall JE, Summers RL, Brands MW, Keen H, Alonso-Garcia M. Resistance to metabolic actions of insulin and its role in hypertension. Am J Hypertens. 1994;7:772-788.
95. Hall JE, Brands MW, Zappe DH, Dixon WN, Mizelle HL, Reinhart GA, Hildebrandt DA. Hemodynamic and renal responses to chronic hyperinsulinemia in obese, insulin-resistant dogs. Hypertension. 1995;25:994-1002.
96. Verma S, Bhanot S, McNeill JH. Effect of chronic endothelin blockade in hyperinsulinemic hypertensive rats. Am J Physiol. 1995; 269:H2017-H2021.
97. Baron AD, Zhu J-S, Marshall S, Irsula O, Brechtel G, Keech C. Insulin resistance after hypertension induced by the nitric oxide synthesis inhibitor L-NMMA in rats. Am J Physiol. 1995;269:E709-E715.
98. Keen HL, Brands MW, Shek EW, Hall JE. Inhibition of thromboxane synthesis attenuates insulin-hypertension in rats. FASEB J. 1996;10:A566. Abstract.
99. Townsend RR, Yamamoto R, Nickols M, DiPette DJ, Nickols GA. Insulin enhances pressor responses to norepinephrine in rat mesenteric vasculature. Hypertension. 1992;19(suppl II):II-105-II-110.
100. 2 in porcine coronary artery. Circulation. 1990;81:1654-1659.
101. Juncos LA, Ito S. Disparate effects of insulin on isolated rabbit afferent and efferent arterioles. J Clin Invest. 1993;92:1981-1985.
102. Peuler JD, Johnson BAB, Phare SM, Sowers JR. Sex-specific effects of insulin secretagogue in stroke-prone hypertensive rats. Hypertension. 1993;22:214-220.
103. Haylor J, Singh I, El-Nahas AM. Nitric oxide synthesis inhibitor prevents vasodilation by insulin like growth factor 1. Kidney Int. 1991;39:333-335.
104. Hirschberg R, Brunori G, Koppel J, Guler HP. Effects of insulin like growth factor-1 on renal function in normal men. Kidney Int. 1993;43:387-397.
105. Hu Y, Pete G, Walsh M, Sowers JR, Dunbar JC. Central IGF-1 decreases systemic blood pressure and increases blood flow in selective vascular beds. Horm Metab Res. 1996;28:211-214.
106. G-Monomethyl-L-arginine inhibits the blood flow but not the insulin-like response of forearm muscle to IGF-1: possible role of nitric oxide in muscle protein synthesis. J Clin Invest. 1996;97:1319-1328.
107. 2+ influx. J Nutr. 1995;125:1732S-1737S.
108. +-ATPase gene expression by insulin in vascular smooth muscle cells. Am J Hypertens. 1993;6:626-629.
109. +-ATPase activity by nitric oxide: a cGMP-independent effect. Am J Physiol. 1994;266:H2146-H2151.
110. Bolotina VM, Najibl S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium dependent potassium channels in vascular smooth muscle. Nature. 1994;368:850-853.
111. 2+ transport. Nature. 1991;349:567-568.
112. +-ATPase activity in rabbit aorta. Diabetologia. 1993;36:2112-2117.
113. Clausen T, Everts ME. Regulation of the Na, K pump in skeletal muscle. Kidney Int. 1989;35:1-13.
114. +-ATPase activity and its alpha II subunit gene expression in rat skeletal muscle: influence of diabetes, fasting, and refeeding. Metabolism. 1992;41:56-63.
115. +-ATPase from intracellular compartments to the plasma membranes in mammalian skeletal muscle. J Biol Chem. 1992; 267:5040-5043.
116. Standley PR, Rose KA, Sowers JR. Increased basal arterial smooth muscle glucose transport in the Zucker rat. Am J Hypertens. 1995;8:48-52.
117. +-ATPase in isolated cerebral microvessels. Am J Physiol. 1993;265:E777-E782.
118. Dominguez LJ, Peuler JD, Sowers JR. Endocrine regulation of vascular smooth muscle intermediary metabolism. In: Sowers JR, ed. Endocrinology of the Vasculature. Totowa, NJ: Humana Press; 1996:325-339.
119. Tare M, Parkington HA, Coleman HA, Nerld TO, Dusting GF. Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium. Nature. 1990;346:69-71.
120. Trovati M, Massucco P, Mattiello L, Cavalot F, Mularoni E, Hahn A, Anfossi G. Insulin increases cyclic nucleotide content in human vascular smooth muscle cells: a mechanism potentially involved in insulin-induced modulation of vascular tone. Diabetes. 1995;38: 936-941.
121. 2+ influx and contraction of serotonin-stimulated vascular smooth muscle cells is reversed by N-mono-methyl-L-arginine. Am J Hypertens. 1996;9: 129A. Abstract.
122. Simmons WW, Closs EI, Cunningham JM, Smith TW, Kelly RA. Cytokine and insulin-induced cationic amino acid transporter (CAT) expression in cardiac myocytes regulation of L-arginine transport and NO production by CAT-1, CAT-2a and Cat-2b. J Biol Chem. 1996;271:11694-11702.
123. Berne C, Gafius J, Pollare T, Hjemdaru P. The sympathetic response to euglycemic hyperinsulinemia: evidence from microelectrode nerve recordings in healthy subjects. Diabetologia. 1992;35:873-879.
124. Vollenweider P, Tappy L, Schneiter P, Jequier E, Nicod P, Scherrer U. Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest. 1993;92:147-154.
125. Mathias CJ, DaCosta DF, Fosbraey P, Christensen NJ, Bannister R. Hypotensive and sedative effects of insulin in autonomie failure. Br Med J. 1987;295:161-163.
126. Pessin JE, Bell GI. Mammalian facilitative glucose transporter family: structure and molecular regulation. Annu Rev Physiol. 1992; 54:911-930.
127. Brosius FC, Briggs JP, Marcus RG, Barac-Nieto M, Charron MJ. Insulin-responsive glucose transporter expression in renal microvessels and glomeruli. Kidney Int. 1992;42:1086-1092.
128. King GL, Buzney SM, Kahn CR, Hetu N, Buchwald S, MacDonald SG, Rand LI. Differential responsiveness to insulin of endothelial and support cells from micro- and macrovessels. J Clin Invest. 1983;71:974-979.
129. 2+ to stimulate glucose transport and GLUT4 translocation in perfused rat heart. Biochim Biophys Acta. 1991; 1094:217-223.
130. Slot JW, Geuze HJ, Gigengack S, James DE, Lienhard GE. Translocation of the glucose transporter GLUT4 in cardiac myocytes of the rat. Proc Natl Acad Sci U S A. 1991;88:7815-7819.
131. Watanabe T, Smith MM, Robinson FW, Kono T. Insulin action on glucose transport in cardiac muscle. J Biol Chem. 1984;259: 13117-13122.
132. Penpargkul S, Shaible T, Yipintsoi T, Scheuer J. The effect of diabetes on performance and metabolism of rat hearts. Circ Res. 1980;47:911-921.
133. Kainulainen H, Breiner J, Schürmann A, Marattinen A, Virjo A, Joost HG. In vivo glucose uptake and glucose transporter proteins GLUT1 and GLUT4 in heart and various types of skeletal muscle from streptozotocin-diabetic rats. Biochim Biophys Acta. 1994; 1225:275-282.
134. Garvey WT, Hardin D, Juhaszova M, Dominguiez JH. Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy. Am J Physiol. 1993;264: H837-H844.
135. Muller DC, Elahi D, Pratley RE, Tobin JD, Andres R. An epidemiological test of the hyperinsulinemia-hypertension hypothesis. J Clin Endocrinol Metab. 1993;76:544-548.
136. Saad MF, Knowler WC, Pettitt DJ. Insulin and hypertension: relationship to obesity and glucose intolerance in Pima Indians. Diabetes. 1990;39:1430-1435.
137. Lembo G, Napoli R, Capaldo B, Rondina V, Iaccanno G, Volpe M, Trimarco B, Sacca L. Abnormal sympathetic overactivity evoked by insulin in skeletal muscle of patients with essential hypertension. J Clin Invest. 1992;90:24-29.
138. Vollendweider P, Randin D, Tappy L, Jequier E, Nicod P, Scherrer U. Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Invest. 1994;93:2365-2371.
139. Tack CJJ, Smits P, Wiollemsen JJ, Lenders JWM, Thien T, Lutterman JAA. Effects of insulin on vascular tone and sympathetic nervous system in NIDDM. Diabetes. 1996;45:15-22.
140. Grassi G, Seravalle G, Cattaneo BM, Bolla GB, Lanfranchi A, Colombo M, Giannattasio C, Brunani A, Cavagnini F, Manda G. Sympathetic activation in obese normotensive subjects. Hypertension. 1995;25:560-563.
141. Ling BN, Seal EE, Eaton DC. Regulation of mesangial cell ion channels by angiotensin II. J Clin Invest. 1993;92:2141-2151.
142. Brands MW, Harrison DL, Keen HL, Hall JE. Insulin-induced hypertension in rats is dependent on an intact renin-angiotensin system. Hypertension. In press.
143. Levy J, Gavin JR III, Sowers JR. Diabetes mellitus: a disease of abnormal cellular calcium metabolism? Am J Med. 1994;96: 260-272.
144. +-dependent adenosine triphosphatase activity in the maintenance of elevated blood pressure in obesity: effects of weight loss. Clin Sci. 1982;63:121S-124S.
145. +)-ATPase activity in kidney basolateral membrane on non-insulin dependent diabetic rats. Biochem Biophys Res Commun. 1987;193:1313-1319.
146. +-ATPase in rat aorta. Diabetes. 1991;40: 1560-1563.
147. +-ATPase α subunit gene expression in hypertension. Science. 1988;241:221-223.
148. Sada T, Koike H, Ikeda M, Sato K, Ozaki H, Karaki H. Cytosolic free calcium of aorta in hypertensive rats. Hypertension. 1990; 16:245-251.
149. Hulman S, Falkner B, Chen YQ. Insulin resistance in the spontaneously hypertensive rat. Metabolism. 1991;40:359-361.
150. 2+-induced inhibition of insulin-stimulated glucose transport. J Biol Chem. 1993;268:3352-3356.
151. Hwang DL, Yen CF, Nadler JL. Insulin increases intracellular magnesium transport in human platelets. J Clin Endocrinol Metab. 1993;76:549-553.
152. Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension. 1993;21:1024-1029.
153. White RE, Hartzell HC. Effects of intracellular free magnesium on calcium current in isolated cardiac myocytes. Science. 1989;239: 778-780.
154. Paolisso G, Sgambato S, Pizza G, Passariello N, Varricchio M, D'Onofrio F. Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects. Diabetes Care. 1989;12:265-268.
155. Fontbonne A, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, Rosselin GE, Eschwége E. Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia. 1991;34:356-361.
156. Welin L, Eriksson H, Larsson B, Ohlson L-O, Svärdsudd K, Tibblin G. Hyperinsulinemia is not a major coronary risk factor in elderly men: the study of men born in 1913. Diabetologia. 1992;35: 766-770.
157. Hargreaves AD, Logan RL, Elton RA, Buchanan KD, Oliver MF, Riemersmaa RA. Glucose tolerance, plasma insulin, HDL cholesterol and obesity: 12-year follow-up and development of coronary heart disease in Edinburgh men. Atherosclerosis. 1992;94:61-69.